EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Cardiac Xenotransplantation: Current State and Future Directions

Katherine G Phillips iD, Imad Aljabban iD, Daniel H Wolbrom iD, Adam Griesemer iD, Marzia Leacche, Christopher McGregor, Nader Moazami iD

Circulation · 08.07.2025 · 152 (1) · 58-73

DOI: 10.1161/circulationaha.124.070875 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Circulation, erschienen am 08.07.2025. Verfasst von Katherine G Phillips und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery (K.G.P., M.L., N.M.), NYU Langone Health, New York, NY. Hauptthemen laut MEDLINE: Transplantation, Heterologous, Heart Transplantation. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 96 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increasing demand for donor hearts presents both a critical challenge and a significant opportunity for innovation in cardiac transplantation. Advancements in immunosuppressive regimens and genetic engineering have reignited recent interest in xenotransplantation. Notably, 2 human patients have received genetically modified pig hearts under expanded-access authorization. They survived for 40 and 60 days, with xenograft failure preceding death in both cases. Concurrently, decedent studies have focused on monitoring the short-term physiological function of genetically modified cardiac xenografts in legally brain-dead recipients, representing a novel experimental paradigm for preclinical testing to help bridge the gap between nonhuman primate studies and clinical trials. These contemporary achievements build on a large body of exploratory efforts in cardiac xenotransplantation in nonhuman primates. Despite significant progress in overcoming hyperacute rejection, adaptive cellular and humoral immunological barriers remain. This review aims to critically evaluate the current advancements in xenotransplantation, to explore ongoing challenges, and to discuss the future potential of this innovative approach in addressing the growing demand for donor organs in cardiac transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transplantation, HeterologousHeart TransplantationHumansAnimalsGraft RejectionSwineAnimals, Genetically ModifiedHeterograftsGraft SurvivalForecasting

Stichwörter der Autor:innen

animals, genetically modifiedgraft rejectionheart transplantationheterograftshumansswinetransplantation, heterologous

Autor:innen und Institutionen

  • Department of Cardiothoracic Surgery (K.G.P., M.L., N.M.), NYU Langone Health, New York, NY.
  • Transplant Institute (I.A., A.G.), NYU Langone Health, New York, NY.
  • Columbia Center for Translational Immunology, Columbia University College of Physicians and Surgeons, New York, NY (D.H.W.).
  • Department of Surgery, University of Minnesota Twin Cities, Minneapolis (C.M.).
  • Institute of Cardiovascular Sciences, UCL, London, UK (C.M.).

ORCID-Profile: Katherine G Phillips, Imad Aljabban, Daniel H Wolbrom, Adam Griesemer, Nader Moazami

Zitieren

APA

Phillips, K. G., Aljabban, I., Wolbrom, D. H., Griesemer, A., Leacche, M., McGregor, C., & Moazami, N. (2025). Cardiac Xenotransplantation: Current State and Future Directions. Circulation, 152(1), 58-73. https://doi.org/10.1161/circulationaha.124.070875

Vancouver

Phillips KG, Aljabban I, Wolbrom DH, Griesemer A, Leacche M, McGregor C, et al. Cardiac Xenotransplantation: Current State and Future Directions. Circulation. 2025;152(1):58-73. doi:10.1161/circulationaha.124.070875

BibTeX
@article{Phillips2025,
  author = {Phillips, Katherine G and Aljabban, Imad and Wolbrom, Daniel H and Griesemer, Adam and Leacche, Marzia and McGregor, Christopher and Moazami, Nader},
  title = {Cardiac Xenotransplantation: Current State and Future Directions},
  journal = {Circulation},
  year = {2025},
  volume = {152},
  number = {1},
  pages = {58--73},
  doi = {10.1161/circulationaha.124.070875}
}
Kostenlos starten →